The Column Group
Highly Engaged Employees
Highly Engaged EmployeesFinance · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1700 Owens St Ste 500, San Francisco, Ca...Phone Number
(415) 865-2050Website
www.thecolumngroup.comRevenue
$7.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
2
2
2
1
About The Column Group
The Column Group (TCG) is a venture ecosystem focused on advancing scientific innovation in the life sciences sector. With a history of funding key advancements in biotechnology, TCG has supported the formation and growth of 55 companies, generating $4.0 billion in returns for its partners. TCG employs an edge-to-edge investment model that nurtures early-stage technology platforms and later-stage programs, ensuring comprehensive support from inception to exit. The firm is dedicated to mentoring CEOs and fostering collaboration within its ecosystem to maximize success in therapeutic breakthroughs.Explore more
The Column Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is The Column Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if The Column Group has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when The Column Group launches new products
The Column Group, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if The Column Group is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if The Column Group had a recent Job posting/layoffs
Earning: See what the market has to say on The Column Group recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at The Column Group
Funding: Get notified immidiatlly once The Column Group has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at The Column Group
Find 2 more new buyers
Compare Similar Companies to The Column Group
Compare insights from companies similar to The Column Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
The Column Group is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
The Column Group is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about The Column Group.
The Column Group Tech Stack
A closer look at the technologies used by The Column Group
Most Recent Scoops
Project
, according to a front-line source in operations management, is in the midst of initiatives related to artificial intelligence and machine learning. The organization is currently evaluating various vendors. The Column Group is expected to increase contingent workforce to support these efforts. These efforts are focused on automation.
Automation, Contingent Workforce, Machine Learning, Artificial Intelligence, Operations
Project
, according to a front-line source in operations management, began leveraging AI-driven workflow and process automation within the last three months.
Automation, Digital Technology, Artificial Intelligence, Operations
Project
, according to a front-line source in operations management, has completed initiatives related to enterprise resource planning (ERP) software within the last twelve months.
Enterprise Software, Software, Enterprise Resource Planning, Operations
Project
, according to a front-line source in operations management, is planning to begin initiatives related to computerized maintenance management systems (CMMS) within six to nine months. The organization is currently evaluating various vendors.
Database, Data Management, Software, Facilities Management, Logistics / Supply Chain, Facilities Maintenance, Operations, Utility Operations
Project
Software, Safety, Health & Safety, Operations
The Column Group News & Media
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer
Nilo Therapeutics launches with $101 million Series A to target neural circuits in immune disease and appoints Kim Seth as Chief Executive OfficerEikon Therapeutics Raises $350.7M in Series D Funding
Eikon Therapeutics, a Hayward, CA-based pivotal-stage biotechnology company for drug discovery and development, raised $350.7M in Series D funding. The investment syndicate was composed of mutual funds, sovereign wealth funds, and healthcare and technology-focused venture firms including Lux Capital, Alexandria Venture Investments, AME Cloud Ventures, The Column Group, E15 VC, Foresite Capital, General Catalyst, Soros […] The post Eikon Therapeutics Raises $350.7M in Series D Funding appeared fi3 months after taking NGM Bio private, VC firm oversees biotech's $122M series A
Three months after The Column Group acquired NGM to take the biotech private, the VC firm has overseen a series A to fund trials of two lead assetsInduPro Announces $85 Million Series A Financing, Appoints Prakash Raman, Ph.D. as CEO to Advance Next-Generation, Proximity-Based Protein Therapeutics for the Treatment of Cancer and Autoimmune Diseases
Developing therapeutics against novel, tumor-selective targets and co-target pairs using bispecific antibodies Series A proceeds fund advancement of the Company's lead programs to clinical readiness and the identification of additional candidates Dr. Raman, a seasoned industry veteran...
Read more news
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding The Column Group
Sign Up For FreeTo access detailed company insights
The Column Group (TCG) is a venture ecosystem focused on advancing scientific innovation in the life sciences sector. With a history of funding key advancements in biotechnology, TCG has supported the formation and growth of 55 companies, generating $4.0 billion in returns for its partners. TCG employs an edge-to-edge investment model that nurtures... Read More
